Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
636 - Can a claim of "Proven efficacy" appear over a presentation of clinical data, if that data was the basis for the product indication?
-
When clinical trial data is presented in advertising it should be clear that the results are based on past study findings. The data should not be presented in a manner which suggests that the results can be expected, or extrapolated beyond the study setting. This applies to all data presentations, including data that Health Canada reviewed as the basis for the product indication. By positioning the term “Proven efficacy” above clinical data it suggests that the results are guaranteed and can be expected by all patients. This would not be accepted over any type of clinical trial data.
